Tag: Gilead long-acting HIV treatment
Twice-Yearly HIV Shot by Gilead Reduces Infections by 96%
Gilead Sciences, a leading pharmaceutical company, has announced groundbreaking results from a second large study on their twice-yearly HIV prevention injectable drug, lenacapavir. According to the company, this innovative shot has demonstrated a remarkable...
FINANCE & STOCK NEWS
BREAKING NEWS
Fed to Maintain Steady Interest Rates on Wednesday
The Federal Reserve is expected to hold interest rates steady today. They are concerned about President Trump's tariffs maybe rekindling inflation and slowing economic...
ADVERTISEMENT
CRYPTO NEWS & MAGAZINE
